TY - JOUR
T1 - Interaction between - 786TC polymorphism in the endothelial nitric oxide synthase gene and smoking for myocardial infarction in Korean population
AU - Jo, Inho
AU - Moon, Jesung
AU - Yoon, Suin
AU - Kim, Hung Tae
AU - Kim, Eunkyung
AU - Park, Hyun Young
AU - Shin, Chol
AU - Min, Jiho
AU - Jin, Yoon Mi
AU - Cha, Seung Hun
AU - Jo, Sangmee Ahn
N1 - Funding Information:
This work was supported in part by research grant from Ministry of Health and Welfare (HMP-00-P-21900-0017) to Drs. Inho Jo, Chol Shin and Hyun-Young Park. We thank Dr. Ho Kim and Ms. Chanmi Park for statistical analysis.
PY - 2006/3
Y1 - 2006/3
N2 - Background: Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) mediates endothelium-dependent vasodilation and antithrombotic action. Controversial results regarding the association of eNOS gene polymorphisms with myocardial infarction (MI) have been reported. Methods: A total of 932 individuals living in Seoul and the suburb, Korea, were randomly selected. Genomic DNA was prepared from blood leukocytes. A GT missense mutation in exon 7 (894GT) was screened using PCR-RFLP analysis. The genotypes of 3 mutations (- 786TC, - 922AG, and - 1468TA) in the 5′-flanking region were determined by a minisequencing protocol (SNaPshot), respectively. Results: Pair-wise linkage analysis revealed that 3 mutations of - 786TC, - 922AG, and - 1468TA were completely linked with each other (|D′| = 1, r2 = 0.96-1.0). Furthermore, each of these mutant alleles (- 786C, - 922G, or - 1468A), but not 894T allele, was associated with the risk of MI. Multiple logistic regression analysis revealed that each of these mutant alleles was a predictive independent risk factor for the risk of MI (odds ratio, 1.69 for dominant effects, P < 0.05) after age and sex adjustments. Smoking further increased the odds ratio by 2.04 for the risk of MI when it was combined with the mutant alleles. Conclusion: Each of 3 mutations (- 786TC, - 922AG, or - 1468TA) in the 5′-flanking region of eNOS gene may play a role in the pathogenesis of MI in Korean population, and also provides an evidence for a significant interaction between these mutations and smoking.
AB - Background: Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) mediates endothelium-dependent vasodilation and antithrombotic action. Controversial results regarding the association of eNOS gene polymorphisms with myocardial infarction (MI) have been reported. Methods: A total of 932 individuals living in Seoul and the suburb, Korea, were randomly selected. Genomic DNA was prepared from blood leukocytes. A GT missense mutation in exon 7 (894GT) was screened using PCR-RFLP analysis. The genotypes of 3 mutations (- 786TC, - 922AG, and - 1468TA) in the 5′-flanking region were determined by a minisequencing protocol (SNaPshot), respectively. Results: Pair-wise linkage analysis revealed that 3 mutations of - 786TC, - 922AG, and - 1468TA were completely linked with each other (|D′| = 1, r2 = 0.96-1.0). Furthermore, each of these mutant alleles (- 786C, - 922G, or - 1468A), but not 894T allele, was associated with the risk of MI. Multiple logistic regression analysis revealed that each of these mutant alleles was a predictive independent risk factor for the risk of MI (odds ratio, 1.69 for dominant effects, P < 0.05) after age and sex adjustments. Smoking further increased the odds ratio by 2.04 for the risk of MI when it was combined with the mutant alleles. Conclusion: Each of 3 mutations (- 786TC, - 922AG, or - 1468TA) in the 5′-flanking region of eNOS gene may play a role in the pathogenesis of MI in Korean population, and also provides an evidence for a significant interaction between these mutations and smoking.
KW - Endothelial nitric oxide synthase gene
KW - Korea
KW - Myocardial infarction
KW - Polymorphism
KW - Smoking
UR - http://www.scopus.com/inward/record.url?scp=32044465749&partnerID=8YFLogxK
U2 - 10.1016/j.cca.2005.07.029
DO - 10.1016/j.cca.2005.07.029
M3 - Article
C2 - 16157324
AN - SCOPUS:32044465749
SN - 0009-8981
VL - 365
SP - 86
EP - 92
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
IS - 1-2
ER -